Endometrial Glandular and Stromal Breakdown (EGBD) as Benign Mimics of Malignancy
- 1 January 2022
- book chapter
- Published by Springer Nature
- p. 155-182
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Papillary Syncytial Metaplasia Associated With Endometrial Breakdown Exhibits an Immunophenotype That Overlaps With Uterine Serous CarcinomaInternational Journal of Gynecological Pathology, 2012
- Endometrial metaplasias and reactive changes: a spectrum of altered differentiationJournal of Clinical Pathology, 2010
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and OutcomesInternational Journal of Gynecological Pathology, 2010
- IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid AdenocarcinomaAmerican Journal of Clinical Pathology, 2010
- Endometrial glandular and stromal breakdown, Part 3: Cytomorphology of “condensed cluster of stromal cells”Diagnostic Cytopathology, 2009
- Diagnostic utility of phosphatase and tensin homolog, β-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparationsCancer, 2008
- Utility of thin-layer preparations in endometrial cytology: Immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesionsDiagnostic Cytopathology, 2008
- Endometrial glandular and stromal breakdown, part 2: Cytomorphology of papillary metaplastic changesDiagnostic Cytopathology, 2006
- Endometrial glandular and stromal breakdown, part 1: Cytomorphological appearanceDiagnostic Cytopathology, 2006
- Endometrial epithelial metaplasiasAmerican Journal of Surgical Pathology, 1980